Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy

Published 2014 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
Authors
Keywords
PARP Inhibition, Ewing Sarcoma, Unacceptable Adverse Event, Ewing Sarcoma Cell, Ewing Sarcoma Cell Line
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-11-06
DOI
10.1186/1471-2407-14-813
References
View 5 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.